Search For
/
Stocks
Intraday Booster
Sector Booster
Stock Screener
Market Pulse
Screeners
More
Go Prime
My Plans
Privacy Policy
Contact
Refer & EarnScreenersMain
Stock Screener
Create Screener
Explore Screeners
Community ScreenersTrading Screeners
CandleSticks Screener
Top Gainers & Losers
Opening Range Breakout
Stock Screener AI
Stock Quality Scorecard
Overvalued StocksNewUndervalued StocksNewTechnical Screeners
NR4 Stocks
NR7 Stocks
Previous Day High Breakout
Previous Day Low Breakout
Previous Day Open Breakout
Bullish Crossover Stocks
Bearish Crossover Stocks
High Volume Shocker
VWAP Breakout Stocks
Range High Breakout
Range Low BreakoutMoreMarkets
Global Market Today
Global Indices
Indian Indices
NIfty TodaySmart Money
FII DII DataNew
FII Buying
NSE Insider Trading
SLB Stocks DataDerivatives
FnO Movements
NSE F&O Lot Size
Ban ListAnalysis & Calendars
Technical DashboardSector Booster
Sector AnalysisNew
Result Calendar
Economic Calendar
Krishna Institute of Medical Sciences
Large Cap•5,264 Employees•IPO 2021
Current Price
₹644.35
-20.05 (-3.02%)Updated
Today's Range
640.2
₹644.35
661.1
52 Week Range
52W Low₹528.05
52W High₹798.40
₹644.35
Downside22.02%
Upside23.91%
Price Chart
Compare with Peers
Historical Ratios
Track top 12 most important financial ratios
P/E Ratio: Price to Earnings - Most used valuation metric
Loading chart...
Analyzing Investment Quality
Processing 9 key metrics...
Key Metrics
Hover for details
Valuation
Market Cap
₹28,407.87 Cr
Market Cap
Total market value of companyP/E Ratio
91.15
P/E Ratio
Price to Earnings. Lower is generally better (<25 is good)P/B Ratio
12.34
P/B Ratio
Price to Book Value. <3 may indicate undervaluationEPS
₹7.50
EPS
Earnings Per Share. Higher and growing is positiveProfitability
ROE
7.65%
ROE
Return on Equity. >15% is good, >20% is excellentROCE
15.00%
ROCE
Return on Capital Employed. >15% is goodNet Margin
8.29%
Net Margin
Net profit as % of revenue. >10% is goodOperating Margin
-%
Operating Margin
Operating profit margin. >15% is goodGrowth
EPS Growth (5Y)
-8.39%
EPS Growth (5Y)
5-year EPS growth. >15% is strongRevenue Growth (5Y)
22.01%
Revenue Growth (5Y)
5-year revenue growth. >10% is goodQtr Sales Growth
26.60%
Qtr Sales Growth
Quarter-over-quarter sales growthQtr Profit Growth
-9.24%
Qtr Profit Growth
Quarter-over-quarter profit growthFinancial Health
Debt/Equity
1.20
Debt/Equity
Financial leverage. <1 is good, <0.5 is excellentBook Value
₹53.43
Book Value
Net asset value per shareDividend Yield
-%
Dividend Yield
Annual dividend as % of price. >2% is goodPromoter Holding
34.10%
Promoter Holding
Promoter stake. >50% shows confidenceGood
Average
Needs Attention
SWOT Analysis
Strengths
3 points- •KIMS demonstrates strong financial efficiency with an 18.5% Return on Equity (ROE) and a healthy 15.0% Return on Capital Employed (ROCE). This indicates effective utilization of shareholder funds, driving robust profitability and sound capital management.
- •KIMS achieved robust quarterly sales growth, reporting a significant 26.6% increase. This positive trend indicates strong market demand and successful expansion strategies, contributing to the company's financial health and future growth potential.
Weaknesses
4 points- •KIMS's high Price-to-Earnings (PE) ratio of 79.70 suggests the stock might be overvalued relative to its earnings. This is higher than peers like Narayana Hrudaya (46.54), potentially posing a risk and warrants careful consideration.
- •The company's debt-to-equity ratio of 1.20 indicates a relatively high level of debt compared to equity. This leverage could increase financial risk, especially during economic downturns or periods of reduced profitability.
Opportunities
2 points- •The healthcare sector, where KIMS operates, is poised for significant growth driven by an aging population, increasing health awareness, and rising disposable incomes. This provides a substantial market expansion opportunity for KIMS.
- •KIMS, with a market cap of ₹29,400 Cr, is smaller than major peers like Max Healthcare (₹115,613 Cr). This indicates significant potential for market share expansion and growth within the competitive healthcare sector.
Threats
3 points- •The highly competitive healthcare sector, with established players like Apollo Hospitals and Max Healthcare, poses a significant threat. Intense competition could pressure KIMS's pricing power and market share, impacting future profitability.
- •Potential adverse regulatory changes or government policies in the healthcare sector could impact KIMS's operations and profitability. Such changes, including pricing controls or new compliance requirements, represent a notable external risk.
Segment-wise Financial Analysis
Fetching Financials...
Fetching Balance Sheet...
Fetching Cash Flow...
Shareholding Pattern
Loading shareholding data...
Company Insider Trading Activity
No insider trading data available
Corporate Action
Company Announcements
Technical Analysis & Indicators
Standard pivot points - most widely used
Pivot Points (CLASSIC)
| Level | Price | Distance | % Change |
|---|---|---|---|
| R4 | ₹698.70 | +₹54.35 | +8.43% |
| R3 | ₹677.80 | +₹33.45 | +5.19% |
| R2 | ₹669.45 | +₹25.10 | +3.90% |
| R1 | ₹656.90 | +₹12.55 | +1.95% |
| PIVOT | ₹648.55 | 4.20 | 0.65% |
| CURRENT | ₹644.35 | - | - |
| S1 | ₹594.20 | -₹50.15 | -7.78% |
| S2 | ₹615.10 | -₹29.25 | -4.54% |
| S3 | ₹627.65 | -₹16.70 | -2.59% |
| S4 | ₹636.00 | -₹8.35 | -1.30% |
CPR Levels
Support
Resistance
S4
N/A
S3
N/A
S2
N/A
S1
N/A
| CPR |
BC: N/AP: N/ATC: N/A
R1
N/A
R2
N/A
R3
N/A
R4
N/A
LTP: N/A
PDH: N/A
PDL: N/A
● Market Sentiment
is trading CPR, indicating
● CPR Width
CPR is
● Opening Range
Day's range: ~
● Price Position
Trading Inside opening range
Delivery Volume Analysis & Trading Activity
Latest Volume-7.5% vs avg
4.02L
(12 Mar 2026)Delivery %+7.5% vs avg
51.1%
(12 Mar 2026)Avg Volume (20D)20-day average
4.34L
(12 Feb - 12 Mar)Avg Delivery %Trend ↑
43.6%
(12 Feb - 12 Mar)Delivery % indicates the percentage of traded volume that resulted in actual delivery. Higher delivery % (>50%) suggests genuine buying interest and stronger hands.
Peer Comparison & Industry Benchmarking
Quick Compare
Largest by Market Cap
Apollo Hospitals Enterprise Ltd
1.09L ₹ Cr
Best Profit Growth
Dr Agarwals Health Care Ltd
151.00 %
Highest Dividend Yield
Rainbow Childrens Medicare Ltd
0.51 %
Peer Comparison
| Company Name |
|---|
 Dr Agarwals Health Care Ltd |
 Apollo Hospitals Enterprise Ltd |
 Aster DM Healthcare Ltd |
 Fortis Healthcare Ltd |
 Healthcare Global Enterprises Ltd |
 Jupiter Life Line Hospitals Ltd |
 |
 Max Healthcare Institute Ltd |
 Global Health Ltd |
 Narayana Hrudayalaya Ltd |
 Rainbow Childrens Medicare Ltd |
 Yatharth Hospital & Trauma Care Services Ltd |
About
Krishna Institute of Medical Sciences Ltd
KIMS Hospitals, officially Krishna Institute of Medical Sciences Limited, is a prominent healthcare provider in India, operating under the KIMS Hospitals brand. Their business centers on delivering a comprehensive range of medical and healthcare services across numerous specialties. This wide-ranging approach allows them to cater to a diverse patient population with varied healthcare needs.
The company's service offerings span a broad spectrum of medical disciplines. Key specialties include cardiology, neurology, oncology, orthopedics, nephrology, reproductive medicine, and robotic surgery. Beyond these core areas, KIMS also provides services in gastroenterology and hepatology, heart and lung transplants, other organ transplantation procedures, mother and childcare, and pediatrics. This comprehensive approach ensures a wide array of patient needs can be addressed within their facilities.
Further specializing their services, KIMS focuses on areas such as accident and emergency care, biochemistry, anesthesiology, bariatric surgery, andrology and infertility treatments, arthroscopy, and Alzheimer's disease management. They also possess expertise in various specialized centers, including bone and joint centers. This detailed specialization allows for targeted expertise and advanced treatment options in specific medical fields.
The breadth of their procedural capabilities is equally impressive. KIMS performs a wide variety of medical procedures, including those related to aneurysms, ankle arthritis and replacements, cervical discectomies and fusions, anterior resections, aortic aneurysms and stent grafts, aortic valve replacements, arthroscopies, atrial septal defects, and bariatric surgeries. This extensive procedural capacity demonstrates a high level of technological and surgical proficiency.
Established in 1973 and headquartered in Secunderabad, India, KIMS Hospitals has a long history of providing healthcare services within the country. Their continued growth and expansion into diverse medical specialties highlights their commitment to providing advanced and comprehensive healthcare solutions to the Indian population.
COMPANY FACTS - KIMS
Registered Address
1-8-31/1, Minister Rd, Krishna Nagar Colony, Begumpet
Secunderabad
TELANGANA
IN
Tel: 914044885000
Website:https://www.kimshospitals.com/
Investor Relations:http://www.kimshospitals.com/investors/
Company Details
Group: Health Care Equipment & Services
Sector: Health Care
Industry: Health Care Providers & Services
Exchange: NATIONAL STOCK EXCHANGE OF INDIA
Employees: 5,264
IPO Date: 28/06/2021
MANAGEMENT - KIMS
Dr. Bhaskara Bollineni
Executive Chairman of the Board, Managing Director
Dr. Abhinay Bollineni
Chief Executive Officer, Executive Director
Mr. Sachin Salvi
Chief Financial Officer
Dr. Nagajayanthi Das
Company Secretary and Compliance Officer
Ms. Anitha Dandamudi
Whole-time Director
Mr. Adwik Bollineni
Non-Executive Non-Independent Director
Dr. Saumen Chakraborty
Non-Executive Independent Director
Mr. Venkata Jasthi
Non-Executive Independent Director
Mr. Ratna Kaza
Non-Executive Independent Director
Mr. Suresh Patel
Non-Executive Independent Director
Mrs. Prameela Yalamanchili
Non-Executive Independent Director
Investor Questions Answered
Krishna Institute of Medical Sciences Ltd (KIMS) Stock FAQs
Get answers to the most common questions about Krishna Institute of Medical Sciences Ltd stock price, fundamentals, financial metrics, and investment analysis
The current share price of Krishna Institute of Medical Sciences Ltd (KIMS) is ₹644.35. Today, the stock has declined by ₹20.05 (3.02%), trading in a range of ₹640.2 to ₹661.1. The stock opened at ₹660 with a trading volume of 2,33,738 shares.
Krishna Institute of Medical Sciences Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹28,407.87 crores, P/E ratio of 91.15, ROE of 7.65%, and ROCE of 15.00%. The dividend yield stands at 0.00%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
The 52-week high price of Krishna Institute of Medical Sciences Ltd (KIMS) is ₹798.4, while the 52-week low is ₹528.05. Currently trading at ₹644.35, the stock is 43.0% away from its 52-week low and 19.3% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
Whether to buy Krishna Institute of Medical Sciences Ltd stock at ₹644.35 depends on multiple factors. The stock is currently trading with a P/E ratio of 91.15 and P/B ratio of N/A. Today's performance shows a loss of 3.02%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
Krishna Institute of Medical Sciences Ltd offers a dividend yield of 0.00%, which means for every ₹100 invested at the current price of ₹644.35, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹2.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
Krishna Institute of Medical Sciences Ltd's key financial metrics include: P/E Ratio: 91.15, P/B Ratio: N/A, ROE: 7.65%, ROCE: 15.00%, Dividend Yield: 0.00%, EPS: ₹7.50, Book Value: ₹53.43, Debt-to-Equity: 1.20, and Current Ratio: N/A. The company's market cap stands at ₹28,407.87 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
Krishna Institute of Medical Sciences Ltd stock opened at ₹660 and is currently trading at ₹644.35, showing a decline of ₹20.05 (3.02%). The intraday high is ₹661.1 and low is ₹640.2. The trading volume stands at 2,33,738 shares, indicating moderate market participation today.
Krishna Institute of Medical Sciences Ltd has a Price-to-Earnings (P/E) ratio of 91.15, which means investors are willing to pay ₹91.15 for every ₹1 of earnings. With an EPS of ₹7.50, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
Krishna Institute of Medical Sciences Ltd has a market capitalization of ₹28,407.87 crores, making it a mid-cap company. Market cap is calculated by multiplying the current stock price (₹644.35) by the total number of outstanding shares. This metric helps investors understand the company's size, stability, and investment risk profile.
Krishna Institute of Medical Sciences Ltd has a book value of ₹53.43 per share and a Price-to-Book (P/B) ratio of N/A. The current market price is ₹644.35, which is 1106.0% above the book value. A P/B ratio below 1 may indicate undervaluation or asset quality concerns.
Krishna Institute of Medical Sciences Ltd has a Return on Equity (ROE) of 7.65% and Return on Capital Employed (ROCE) of 15.00%. ROE measures how efficiently the company generates profits from shareholders' equity, while ROCE indicates how well the company uses its capital to generate profits. These returns may need improvement for better profitability. Higher percentages generally indicate better financial performance.
Krishna Institute of Medical Sciences Ltd operates in the diversified sector and belongs to the general industry. The company competes with other players in this space and its performance is influenced by sector-specific trends, regulatory changes, and market dynamics. Understanding the sector helps investors assess growth potential, cyclical patterns, and industry-specific risks that may impact the stock's performance.
Krishna Institute of Medical Sciences Ltd has a debt-to-equity ratio of 1.20, which measures the company's financial leverage by comparing total debt to shareholders' equity. A ratio above 1 suggests the company uses more debt than equity for financing. Lower ratios generally indicate lower financial risk, but optimal levels vary by industry.
Krishna Institute of Medical Sciences Ltd has an Earnings Per Share (EPS) of ₹7.50, which represents the company's profit allocated to each outstanding share. With a current stock price of ₹644.35 and P/E ratio of 91.15, investors are paying 91.15 times the annual earnings per share. The company may need to improve its earnings performance. Track EPS growth over quarters to assess earnings momentum.
Krishna Institute of Medical Sciences Ltd has reported a sales growth of N/A% and profit growth of N/A%. The company may be facing growth challenges or operating in a mature market. Consistent growth over multiple quarters is a positive indicator for long-term investors. Compare these growth rates with industry peers for better perspective.
Krishna Institute of Medical Sciences Ltd has a current ratio of N/A, which measures the company's ability to pay short-term obligations with current assets. A ratio below 1 may indicate potential liquidity concerns. This metric is crucial for assessing the company's working capital management and financial safety.
To analyze Krishna Institute of Medical Sciences Ltd stock, consider: 1) Fundamental Analysis - Review P/E (91.15), ROE (7.65%), debt-to-equity (1.20), and growth rates. 2) Technical Analysis - Check 52-week range (₹528.05 - ₹798.40), moving averages, and chart patterns. 3) Valuation - Compare current price (₹644.35) with book value (₹53.43) and industry peers. 4) Financial Health - Assess current ratio (N/A) and cash flows. 5) Growth Prospects - Evaluate sales growth (N/A%) and profit growth (N/A%). Always diversify and consult a financial advisor.
The face value (or par value) of Krishna Institute of Medical Sciences Ltd share is ₹2.00. Face value is the nominal value of a share as stated in the company's charter and is used for accounting purposes and calculating dividends. The current market price of ₹644.35 is 32118x the face value. Face value remains constant unless the company undergoes a stock split or bonus issue, while market price fluctuates based on demand and supply.
Investing in Krishna Institute of Medical Sciences Ltd carries several risks: 1) Market Risk - Stock price volatility (52-week range: ₹528.05 - ₹798.40). 2) Business Risk - Industry-specific challenges in the sector. 3) Financial Risk - Debt-to-equity ratio of 1.20 indicates leverage. 4) Liquidity Risk - Based on trading volume of 2,33,738 shares. 5) Valuation Risk - P/E of 91.15 may indicate over/undervaluation. 6) Economic Risk - Macroeconomic factors affecting the industry. Diversify your portfolio and invest only what you can afford to lose.
Krishna Institute of Medical Sciences Ltd operates in the industry with key metrics: P/E ratio of 91.15, ROE of 7.65%, market cap of ₹28,407.87 crores, and dividend yield of 0.00%. To make an informed comparison, analyze these metrics against industry peers considering factors like revenue growth (N/A%), profit margins, debt levels (D/E: 1.20), and market position. Use our peer comparison tool on this page to see detailed side-by-side analysis with competitors.
Target prices for Krishna Institute of Medical Sciences Ltd vary among analysts and depend on multiple factors including earnings projections, industry trends, and market conditions. The stock is currently trading at ₹644.35, with a 52-week range of ₹528.05 to ₹798.40. Based on fundamentals like P/E (91.15), ROE (7.65%), and growth rates, analysts may have different target prices. Always refer to recent research reports from reputed brokerages and make decisions based on your own analysis and risk appetite.
Consider selling Krishna Institute of Medical Sciences Ltd stock when: 1) Target Price Achieved - If the stock reaches your predetermined target from current ₹644.35. 2) Fundamental Deterioration - Declining ROE (currently 7.65%), increasing debt (D/E: 1.20), or falling growth rates. 3) Better Opportunities - Finding stocks with superior risk-reward ratios. 4) Portfolio Rebalancing - When the stock becomes overweight in your portfolio. 5) Changed Investment Thesis - If reasons for buying no longer hold. 6) Stop Loss - If price falls below your risk threshold. Always base decisions on thorough analysis rather than emotions.
Tax implications for Krishna Institute of Medical Sciences Ltd stock investments: 1) Short-term Capital Gains (STCG) - If sold within 1 year, gains taxed at 15% plus cess. 2) Long-term Capital Gains (LTCG) - If held over 1 year, gains above ₹1 lakh taxed at 10% without indexation. 3) Dividend Income - Dividends (current yield: 0.00%) are taxable as per your income tax slab. 4) Securities Transaction Tax (STT) - Applicable on both buy and sell transactions. 5) Intraday Trading - Treated as speculative income, taxed as per slab. Tax laws change periodically, so consult a tax advisor for personalized guidance and latest regulations.
Menu